Unni Hjelmaas, CEO in Lytix Biopharma, and Øystein Rekdal, CSO, gave a presentation of the company at Arctic Securities' Biotech Seminar in Oslo March 2nd 2015. They received good feedback on their presentation from investors and other companies attending the seminar.

See the presentation here.